We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$64.6B
AUM Growth
+$5.95B
Cap. Flow
+$299M
Cap. Flow %
0.46%
Top 10 Hldgs %
11.91%
Holding
4,318
New
702
Increased
1,590
Reduced
1,355
Closed
633

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$653M
2
AMZN icon
Amazon
AMZN
+$602M
3
XOM icon
ExxonMobil
XOM
+$473M
4
TSLA icon
Tesla
TSLA
+$437M
5
SBUX icon
Starbucks
SBUX
+$380M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 17.69%
3 Consumer Discretionary 13.09%
4 Industrials 7.96%
5 Consumer Staples 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GURE
3001
Gulf Resources
GURE
$4.71M
$291K ﹤0.01%
17,649
-1,380
-7% -$22.3K
SCTL
3002
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$291K ﹤0.01%
831,217
-4,800
-0.6% -$1.75K
MTEX icon
3003
Mannatech
MTEX
$10.4M
$290K ﹤0.01%
35,799
-1,600
-4% -$14.3K
SMR icon
3004
NuScale Power
SMR
$3.89B
$290K ﹤0.01%
+88,200
New +$313K
DFAT icon
3005
Dimensional US Targeted Value ETF
DFAT
$14.9B
$288K ﹤0.01%
5,500
-9,900
-64% -$463K
ECOR icon
3006
electroCore
ECOR
$90.5M
$288K ﹤0.01%
48,416
+5,800
+14% +$33.3K
JVA icon
3007
Coffee Holding Co
JVA
$20.1M
$288K ﹤0.01%
315,964
-6,000
-2% -$4.82K
SWKH
3008
DELISTED
SWK Holdings
SWKH
$287K ﹤0.01%
20,697
+1,893
+10% +$24.7K
EDUC icon
3009
Educational Development Corp
EDUC
$11.8M
$285K ﹤0.01%
245,545
+2,800
+1% +$2.7K
REPL icon
3010
Replimune Group
REPL
$1.42B
$285K ﹤0.01%
33,853
-52,847
-61% -$613K
SPRY icon
3011
ARS Pharmaceuticals
SPRY
$574M
$285K ﹤0.01%
52,000
-85,700
-62% -$375K
WU icon
3012
Western Union
WU
$2.3B
$285K ﹤0.01%
+23,921
New +$292K
BWEN icon
3013
Broadwind
BWEN
$125M
$282K ﹤0.01%
101,700
-5,928
-6% -$15.7K
GOLF icon
3014
Acushnet Holdings
GOLF
$5.23B
$278K ﹤0.01%
4,400
-67,000
-94% -$3.76M
WIMI
3015
WiMi Hologram Cloud
WIMI
$24.3M
$278K ﹤0.01%
34,360
-160
-0.5% -$1.09K
CMPX icon
3016
Compass Therapeutics
CMPX
$403M
$276K ﹤0.01%
176,799
+149,999
+560% +$260K
RVP icon
3017
Retractable Technologies
RVP
$20.5M
$276K ﹤0.01%
248,574
+40,310
+19% +$45.1K
NRGD
3018
DELISTED
MicroSectors US Big Oil -3x Inverse Leveraged ETN
NRGD
$276K ﹤0.01%
1,200
-500
-29% -$117K
NFGC
3019
New Found Gold
NFGC
$641M
$275K ﹤0.01%
+78,700
New +$298K
DAVE icon
3020
Dave Inc
DAVE
$4.35B
$274K ﹤0.01%
+32,700
New +$204K
SDPI
3021
DELISTED
Superior Drilling Products Inc.
SDPI
$273K ﹤0.01%
381,810
-133,431
-26% -$98K
TEAD
3022
Teads Holding Co
TEAD
$66.7M
$272K ﹤0.01%
62,000
-18,300
-23% -$77.5K
AKTS
3023
DELISTED
Akoustis Technologies Inc
AKTS
$272K ﹤0.01%
325,900
-280,758
-46% -$189K
BH.A icon
3024
Biglari Holdings Class A
BH.A
$1.2B
$270K ﹤0.01%
340
+10
+3% +$7.73K
HUMA icon
3025
Humacyte
HUMA
$163M
$270K ﹤0.01%
95,100
-12,400
-12% -$31.8K

Similar funds

Jim Simons's Q4 2023 Portfolio in Review

As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
  • Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
  • Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
  • Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
  • Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
  • Jim Simons opened 702 new positions and closed 633 in Q4 2023.
  • Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.